WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO1998003185) REMEDIES FOR HYPERPHOSPHATEMIA
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/1998/003185    International Application No.:    PCT/JP1997/002486
Publication Date: 29.01.1998 International Filing Date: 17.07.1997
Chapter 2 Demand Filed:    29.01.1998    
IPC:
A61K 31/78 (2006.01), A61K 31/785 (2006.01), A61K 33/26 (2006.01)
Applicants: NIKKEN CHEMICALS CO., LTD. [JP/JP]; 4-14, Tsukiji 5-chome, Chuo-ku, Tokyo 104 (JP) (For All Designated States Except US).
SASAKI, Yoshiyuki [JP/JP]; (JP) (For US Only).
ISHII, Yutaka [JP/JP]; (JP) (For US Only)
Inventors: SASAKI, Yoshiyuki; (JP).
ISHII, Yutaka; (JP)
Agent: IMAMURA, Masazumi @.; KRF Building, 5th floor, 5-5, Kyobashi 1-chome, Chuo-ku, Tokyo 104-0031 (JP)
Priority Data:
8/207574 19.07.1996 JP
9/31461 31.01.1997 JP
Title (EN) REMEDIES FOR HYPERPHOSPHATEMIA
(FR) REMEDES CONTRE L'HYPERPHOSPHATEMIE
Abstract: front page image
(EN)Drugs containing as the active ingredient weakly basic anion exchange resins carrying ferric ions bonded thereto via a chelate bond, preferably polyamide or acrylic resins. These drugs are excellent in adsorptivity and selectivity for phosphate ions and thus efficiently adsorb phosphate ions $i(in vivo), which makes them useful in the treatment and/or prevention of hyperphosphatemia.
(FR)L'invention concerne des médicaments contenant, comme principe actif, des résines échangeuses d'ions faiblement basiques, portant des ions ferriques liés à celles-ci par une liaison à chélate, de préférence des résines polyamines ou acryliques. Ces médicaments présentent une excellente adsorptivité et sélectivité pour les ions phosphate et adsorbent donc efficacement les ions phosphate $i(in vivo), ce qui les rend utiles dans le traitement et/ou la prévention de l'hyperphosphatémie.
Designated States: CA, CN, JP, KR, NO, US.
European Patent Office (AT, BE, CH, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE).
Publication Language: Japanese (JA)
Filing Language: Japanese (JA)